Gefitinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

NCT00014170 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

92

Enrollment

NIH

Sponsor class

Conditions

Adult Giant Cell Glioblastoma
Adult Glioblastoma
Adult Gliosarcoma

Interventions

DRUG: gefitinib
OTHER: pharmacological study
OTHER: laboratory biomarker analysis
OTHER: questionnaire administration
PROCEDURE: quality-of-life assessment

Sponsor

National Cancer Institute (NCI)